Salvianolic acid B-vitamin C synergy in cardiac differentiation from embryonic stem cells

Biochemical and Biophysical Research Communications

Volumn 387, Issue 4, 2009, Pages 723-728

  Chan, Sunny Sun Kin ^a   Chen, Jyh Hong ^a   Hwang, Shiaw Min ^b   Wang, I Ju ^a   Li, Hui Jing ^a   Lee, Richard T ^c   Hsieh, Patrick C H ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Cardiomyocyte differentiation; Embryonic stem cells; Natural products

Indexed keywords

ASCORBIC ACID; ENHANCED GREEN FLUORESCENT PROTEIN; MYOSIN HEAVY CHAIN ALPHA; SALVIANOLIC ACID B;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HEART PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ANIMALS; ASCORBIC ACID; BENZOFURANS; CARDIOTONIC AGENTS; CELL DIFFERENTIATION; CELL LINE; COLLAGEN; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; EMBRYONIC STEM CELLS; MICE; MYOCYTES, CARDIAC; VITAMINS;

EID: 68549097783     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.122     Document Type: Article

References (30)

1. Segers V.F., and Lee R.T. Stem-cell therapy for cardiac disease. Nature 451 (2008) 937-942
2. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Reinecke H., Xu C., Hassanipour M., Police S., O'Sullivan C., Collins L., Chen Y., Minami E., Gill E.A., Ueno S., Yuan C., Gold J., and Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25 (2007) 1015-1024
3. Singh A.M., Li F., Hamazaki T., Kasahara H., Takemaru K., and Terada N. N. Chibby, an antagonist of the Wnt/β-catenin pathway, facilitates cardiomyocyte differentiation of murine embryonic stem cells. Circulation 115 (2007) 617-626
4. Yuasa S., Itabashi Y., Koshimizu U., Tanaka T., Sugimura K., Kinoshita M., Hattori F., Fukami S., Shimazaki T., Ogawa S., Okano H., and Fukuda K. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat. Biotechnol. 23 (2005) 607-611
5. Sadek H., Hannack B., Choe E., Wang J., Latif S., Garry M.G., Garry D.J., Longgood J., Frantz D.E., Olson E.N., Hsieh J., and Schneider J.W. Cardiogenic small molecules that enhance myocardial repair by stem cells. Proc. Natl. Acad. Sci. USA 105 (2008) 6063-6068
6. Wu X., Ding S., Ding Q., Gray N.S., and Schultz P.G. Small molecules that induce cardiomyogenesis in embryonic stem cells. J. Am. Chem. Soc. 126 (2004) 1590-1591
7. Wu X., Shi T., and Ding S. A chemical approach to stem-cell biology and regenerative medicine. Nature 453 (2008) 338-344
8. Takahashi T., Lord B., Schulze P.C., Fryer R.M., Sarang S.S., Gullans S.R., and Lee R.T. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107 (2003) 1912-1916
9. Levkau B., Schäfers M., Wohlschlaeger J., Von Wnuck Lipinski K., Keul P., Hermann S., Kawaguchi N., Kirchhof P., Fabritz L., Stypmann J., Stegger L., Flögel U., Schrader J., Fischer J.W., Hsieh P., Ou Y.L., Mehrhof F., Tiemann K., Ghanem A., Matus M., Neumann J., Heusch G., Schmid K.W., Conway E.M., and Baba H.A. Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation 117 (2008) 1583-1593
10. Hsieh P.C., Davis M.E., Gannon J., MacGillivray C., and Lee R.T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Invest. 116 (2006) 237-248
11. Chan S.S., Jones R.L., and Lin G. Synergistic interaction between the Ligusticum chuanxiong constituent butylidenephthalide and the nitric oxide donor sodium nitroprusside in relaxing rat isolated aorta. J. Ethnopharmacol. 122 (2009) 308-312
12. X.H. Ma, C.J. Zheng, L.Y. Han, B. Xie, J. Jia, Z.W. Cao, Y.X. Li, Y.Z. Chen, Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives, Drug Discov. Today (2009), doi:10.1016/j.drudis.2009.03.012.
13. Sato H., Takahashi M., Ise H., Yamada A., Hirose S., Tagawa Y., Morimoto H., Izawa A., and Ikeda U. Collagen synthesis is required for ascorbic acid-enhanced differentiation of mouse embryonic stem cells into cardiomyocytes. Biochem. Biophys. Res. Commun. 342 (2006) 107-112
14. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
15. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., and Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322 (2008) 949-953
16. Stadtfeld M., Nagaya M., Utikal J., Weir G., and Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 322 (2008) 945-949
17. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., Isacson O., and Jaenisch R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136 (2009) 964-977
18. K. Kaji, K. Norrby, A. Paca, M. Mileikovsky, P. Mohseni, K. Woltjen, Virus-free induction of pluripotency and subsequent excision of reprogramming factors, Nature (2009), doi:10.1038/nature07864.
19. K. Woltjen, I.P. Michael, P. Mohseni, R. Desai, M. Mileikovsky, R. Hämäläinen, piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells, Nature (2009), doi:10.1038/nature07863.
20. Mauritz C., Schwanke K., Reppel M., Neef S., Katsirntaki K., Maier L.S., Nguemo F., Menke S., Haustein M., Hescheler J., Hasenfuss G., and Martin U. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118 (2008) 507-517
21. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., Matsuoka S., Yamanaka S., and Yamashita J.K. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118 (2008) 498-506
22. Tang W., and Eisenbrand G. Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine (1992), Springer-Verlag, Berlin, Germany
23. Ji X.Y., Tan B.K., and Zhu Y.Z. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol. Sin. 21 (2000) 1089-1094
24. The State Pharmacopoeia Commission of the People's Republic of China, Pharmacopoeia of the People's Republic of China, vol. 1, Chemical Industry Press, Beijing, China, 2005.
25. Lam F.F., Yeung J.H., Kwan Y.W., Chan K.M., and Or P.M. Salvianolic acid B, an aqueous component of danshen (Salvia miltiorrhiza), relaxes rat coronary artery by inhibition of calcium channels. Eur. J. Pharmacol. 553 (2006) 240-245
26. Lay I.S., Hsieh C.C., Chiu J.H., Shiao M.S., Lui W.Y., and Wu C.W. Salvianolic acid B enhances in vitro angiogenesis and improves skin flap survival in Sprague-Dawley rats. J. Surg. Res. 115 (2003) 279-285
27. Chen Y.L., Hu C.S., Lin F.Y., Chen Y.H., Sheu J.M., Ku H.H., Shiao M.S., Chen J.W., and Lin S.J. Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta. J. Cell. Biochem. 98 (2006) 618-631
28. Liu C.L., Xie L.X., Li M., Durairajan S.S.K., Goto S., and Huang J.D. Salvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signaling. PLoS One 12 (2007) e1321
29. Hsieh P.C., Segers V.F., Davis M.E., MacGillivray C., Gannon J., Molkentin J.D., Robbins J., and Lee R.T. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 13 (2007) 970-974
30. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabé-Heider F., Walsh S., Zupicich J., Alkass K., Buchholz B.A., Druid H., Jovinge S., and Frisén J. Evidence for cardiomyocyte renewal in humans. Science 324 (2009) 98-102